EZH2 inhibitor enhances the STING agonist-induced antitumor immunity in melanoma. Xu T, Dai J, Tang L, Yang L, et al. J Invest Dermatol 2021 Sep 24. pii: S0022-202X(21)02227.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu T, Dai J, Tang L, Yang L, et al. EZH2 inhibitor enhances the STING agonist-induced antitumor immunity in melanoma. J Invest Dermatol 2021 Sep 24. pii: S0022-202X(21)02227.
PMID: 34571002